Bactiquant Financial Statements From 2010 to 2025
| BACTIQ Stock | DKK 3.68 0.02 0.54% |
Check Bactiquant financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bactiquant's main balance sheet or income statement drivers, such as , as well as many indicators such as . Bactiquant financial statements analysis is a perfect complement when working with Bactiquant Valuation or Volatility modules.
Bactiquant |
Bactiquant AS Company Price To Book Analysis
Bactiquant's Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Current Bactiquant Price To Book | 9.57 X |
Most of Bactiquant's fundamental indicators, such as Price To Book, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bactiquant AS is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
| Competition |
Based on the latest financial disclosure, Bactiquant AS has a Price To Book of 9.5735 times. This is 62.26% higher than that of the Industrials sector and 121.61% higher than that of the Pollution & Treatment Controls industry. This indicator is about the same for all Denmark stocks average (which is currently at 9.51).
Bactiquant AS Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Bactiquant's current stock value. Our valuation model uses many indicators to compare Bactiquant value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bactiquant competition to find correlations between indicators driving Bactiquant's intrinsic value. More Info.Bactiquant AS is the top company in current valuation category among its peers. It also is number one stock in shares outstanding category among its peers creating about 0.14 of Shares Outstanding per Current Valuation. The ratio of Current Valuation to Shares Outstanding for Bactiquant AS is roughly 7.02 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Bactiquant by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Bactiquant's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Bactiquant Financial Statements
Bactiquant stakeholders use historical fundamental indicators, such as Bactiquant's revenue or net income, to determine how well the company is positioned to perform in the future. Although Bactiquant investors may analyze each financial statement separately, they are all interrelated. For example, changes in Bactiquant's assets and liabilities are reflected in the revenues and expenses on Bactiquant's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Bactiquant AS. Please read more on our technical analysis and fundamental analysis pages.
Bactiquant AS develops and provides technology for the mobile and online surveillance of bacterial contamination levels in water. The company is based in 1998 and is based in Horsholm, Denmark. BactiQuant is traded on Copenhagen Stock Exchange in Denmark.
Pair Trading with Bactiquant
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bactiquant position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bactiquant will appreciate offsetting losses from the drop in the long position's value.Moving against Bactiquant Stock
| 0.59 | CARL-B | Carlsberg AS | PairCorr |
| 0.55 | DANSKE | Danske Bank AS | PairCorr |
| 0.51 | ISS | ISS AS | PairCorr |
| 0.46 | MAERSK-A | AP Mller | PairCorr |
| 0.41 | CARL-A | Carlsberg AS | PairCorr |
The ability to find closely correlated positions to Bactiquant could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bactiquant when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bactiquant - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bactiquant AS to buy it.
The correlation of Bactiquant is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bactiquant moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bactiquant AS moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bactiquant can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Bactiquant Stock
Bactiquant financial ratios help investors to determine whether Bactiquant Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bactiquant with respect to the benefits of owning Bactiquant security.